A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma

por Seddon, Beatrice, Scurr, Michelle, Jones, Robin L, Wood, Zoe, Propert-Lewis, Cerys, Fisher, Cyril, Flanagan, Adrienne, Sunkersing, Jonanthan, A’Hern, Roger, Whelan, Jeremy, Judson, Ian
Publicado 2015